Clinical Trial Update: A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ONO-2020 for agitation associated with Alzheimer's disease dementia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ONO-2020

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Agitation Associated With Alzheimer's Disease Dementia | Phase 2 | Status: RECRUITING